AZTAMEDIUM SIGNALOPERATIONAL10-K

AZTA is executing a comprehensive transformation plan involving significant operational restructuring, goodwill reallocation, and increased capital investments while showing strong revenue growth but persistent losses.

The company has implemented a new organizational structure requiring goodwill reallocation and is incurring substantial "transformation costs" for strategic projects aimed at long-term operational improvements. While revenue growth of 37% is encouraging, the company remains unprofitable and is investing heavily in both capital expenditures and R&D, suggesting they are in an intensive restructuring phase that may pressure near-term profitability.

Comparing 2025-12-04 vs 2024-11-27View on EDGAR →
FINANCIAL ANALYSIS

AZTA delivered strong top-line growth with revenue increasing 37% to $593.8M and gross profit rising proportionally to $270.3M, indicating healthy demand and maintained margins. However, the company remains loss-making despite cutting net losses in half from -$106.6M to -$55.8M, while simultaneously ramping up investments with capital expenditures surging 337% to $33.9M and R&D spending up 37% to $30.4M. The combination of declining cash reserves, doubled interest expenses, and heavy investment spending suggests AZTA is in a capital-intensive transformation phase that investors should monitor closely for execution progress.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
+336.9%
$7.8M→$33.9M

Capital expenditure jumped 336.9% — major investment cycle underway; assess returns on deployment.

Interest Expense
P&L
+125.3%
$2.0M→$4.6M

Interest expense surged 125.3% — significant debt increase or rising rates materially impacting earnings.

Net Income
P&L
+47.7%
-$106.6M→-$55.8M

Net income grew 47.7% — bottom-line growth signals improving overall business health.

R&D Expense
P&L
+37.3%
$22.1M→$30.4M

R&D investment increased 37.3% — signals commitment to future product development, though near-term margin impact.

Revenue
P&L
+36.6%
$434.6M→$593.8M

Strong top-line growth of 36.6% — accelerating demand or successful expansion into new markets.

Gross Profit
P&L
+36.5%
$198.0M→$270.3M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

SG&A Expense
P&L
+30.9%
$199.9M→$261.6M

SG&A up 30.9% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Cash & Equivalents
Balance Sheet
-10%
$310.9M→$279.8M

Cash decreased 10% — monitor burn rate and upcoming capital needs.

LANGUAGE CHANGES
NEW — 2025-12-04
PRIOR — 2024-11-27
ADDED
As a result of this segment realignment, the Company allocated goodwill to the reporting units existing under the new organizational structure on a relative fair value basis as of October 1, 2023.
Transformation costs represent non-recurring expenses for strategic projects with anticipated long-term benefits to the Company focused on cost reduction and productivity improvement that do not meet the definition of restructuring charges.
These costs are directed at simplifying, standardizing, streamlining, and optimizing the Company s operations, processes and systems to permanently alter the Company s operations for the long term.
For a project to be considered transformational, successful completion of the project must be expected to bring long-term material benefits to the organization and involve significant changes to process and/or underlying technology.
Transformation costs in the period result from actions taken as part of the Company s 2024 transformation plan and primarily relate to one time asset write downs associated with changes in technology, one time inventory write downs relating to restructuring actions taken in the period, and third-party consulting costs associated with process and systems re-design.
+7 more — sign up free →
REMOVED
Joseph Senior Vice President, General Counsel and Secretary true 21,000 Core Products are Automated Stores, Cryogenic Systems, Automated Sample Tube, and Consumables and Instruments.
As of March 28, 2024, 55,003,056 shares of the registrant s Common Stock, $0.01 par value, were outstanding.
As of November 19, 2024, 45,583,205 shares of the registrant s Common Stock, $0.01, par value, were outstanding.
All statements that are not historical facts, including statements about our beliefs or expectations, are forward-looking statements.
These statements may be identified by such forward-looking, terminology as expect, estimate, intend, believe, anticipate, may, will, should, could, continue, likely or similar statements or variations of such terms.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →